Results 81 to 90 of about 12,210 (151)

Real-world cost evaluation of conbercept vs. ranibizumab for retinal and choroidal vascular diseases from 2021 to 2024: evidence from societal and medical insurance perspectives. [PDF]

open access: yesBMC Public Health
Liu Y   +12 more
europepmc   +1 more source

Long-Term Management of Polypoidal Choroidal Vasculopathy: A Narrative Review. [PDF]

open access: yesOphthalmol Ther
Koh A   +6 more
europepmc   +1 more source

Systemic and ocular complications related to intravitreal administration of anti-VEGF agents. [PDF]

open access: yesMed Hypothesis Discov Innov Ophthalmol
Koksaldi S   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy